ProSolv introduces next-generation cardiovascular app

TriMed Staff | | Health Imaging | Diagnostic Imaging
ProSolv CardioVascular, a FujiFilm company, has released its ProSolv CardioVascular 4.0, a web-based application for full viewing and reporting capabilities using web communication protocols, secured via SSL. The application can be downloaded and installed via a web URL. 

Other enhancements to the software include new clinical tools to further aid the diagnostic process, and the integration to Fujifilm Medical Systems’ Synapse PACS, according to the Indianapolis-based ProSolv. 

The company said that new clinical reporting features include pediatric echo reporting and a z-score module, so users can report more than 40 pediatric measurements and calculations against the normal ranges and z-scores. For nuclear cardiology, Invia 4DM-SPECT version 5.2 is now supported, offering features like saved state. Other new enhancements introduced include a new default echo measurement analysis package, updates to coronary tree functionality and resting ECG management, including Holter monitoring support delivered by the application’s OpenECG Module, powered by Epiphany.

ProSolv CardioVascular 4.0 is immediately being rolled out across the United States.

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.